Print page Close print preview
Logo Going International
New search | Conferencedetail

4th Annual Cell Engager Therapeutics Summit 2022 | May 24-26 2022 | Boston, MA

Evvnt Promotion / evvnt
24.05.2022 - 26.05.2022  Boston Park Plaza, 50 Park Plaza, 02116 Boston, USA
Time: 09:00 - 15:00
Conference themes
With TCEs being studied in both hematological and solid tumors (39 and 34 trials respectively), there are now more than one hundred projects in the preclinical stage.
Early clinical outcomes and novel TCE design modifications have fueled the development and clinical advancement of over 65 bispecific T-cell engagers (TCEs), which are presently in Phase I and Phase II investigations since the Cell Engager Series began.
Professional congress organizer (PCO)
Hanson Wade
Speakers: Antara Banerjee Associate Director, Immunology Research and Group Leader, Immuno Biologics Takeda Pharmaceutical Co. Ltd., Julie Bailis Director of Research Amgen Inc and more.

Enquiries and Registration:
Ms. Rosie Andre
General Medicine
Congress fees
USD 2599.0 - USD 4648.0
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom